Showing results (21-30 of 771) with videos related to
Sort By:
Pageof 78
Cardiology in Review|June 22, 2006
Chymase: a new pharmacologic target in cardiovascular diseaseChristopher Bacani, William H FrishmanCardiology in Review|December 5, 2022
AVACOPAN: A New Adjunctive Therapy for Antineutrophil Cytoplasmic Antibody-Associated VasculitisJasmine Garg, William H FrishmanCardiology in Review|May 16, 2022
Cardiovascular and Hematologic Complications of COVID-19 VaccinesJordana Herblum, William H FrishmanCardiology in Review|October 7, 2017
Neprilysin Inhibition and the Treatment of Heart Failure: Recent Steps in the Right DirectionNicholas Bartell, William H FrishmanCardiology in Review|April 23, 2019
Angiopoietin-Like 3 Protein Inhibition: A New Frontier in Lipid-Lowering TreatmentWilliam Lang, William H FrishmanCardiology in Review|December 8, 2010
Soluble guanylate cyclase activation with cinaciguat: a new approach to the treatment of decompensated heart failureShipra Hingorany, William H FrishmanCardiology in Review|October 8, 2010
Relaxin: a new approach for the treatment of acute congestive heart failureJason Grossman, William H FrishmanCardiology in Review|December 7, 2011
Vitamin D: a cardioprotective agent?Yaakov Liss, William H FrishmanAmerican Journal of Therapeutics|April 1, 1995
Ranolazine: A New Anti-Ischemic Drug Which Affects Myocardial EnergeticsMarc Goldschmidt, William H. FrishmanCardiology in Review|October 19, 2017
Effects of Anti-Inflammatory Medications in Patients With Coronary Artery Disease: A Focus on LosmapimodBradley Tun, William H FrishmanPageof 78